$RM Balance Sheet | Understand Stock

$RM

$32.89 +$0.35 (1.08%) Close

$RM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash
Variable Interest Entity, Primary Beneficiary
Total cash
Net finance receivables
Variable Interest Entity, Primary Beneficiary
Total net finance receivables
Unearned insurance premiums
Allowance for credit losses
Variable Interest Entity, Primary Beneficiary
Total allowance for credit losses
Net finance receivables, less unearned insurance premiums and allowance for credit losses
Restricted cash
Variable Interest Entity, Primary Beneficiary
Total restricted cash
Lease assets
Intangible assets
Restricted AFS investments
Property and equipment
Deferred tax assets, net
Other assets
Variable Interest Entity, Primary Beneficiary
Total other assets
Variable Interest Entity, Primary Beneficiary
Total assets
Liabilities:
Debt
Unamortized debt issuance costs
Net debt
Variable Interest Entity, Primary Beneficiary
Total net debt
Lease liabilities
Deferred tax liability, net
Accounts payable and accrued expenses
Variable Interest Entity, Primary Beneficiary
Total accounts payable and accrued expenses
Other liabilities
Variable Interest Entity, Primary Beneficiary
Total other liabilities
Variable Interest Entity, Primary Beneficiary
Total liabilities
Stockholders’ equity:
Common stock ($0.10 par value, 1,000,000 shares authorized, 15,298 shares issued and 9,340 shares outstanding at June 30, 2026 and 15,168 shares issued and 9,554 shares outstanding at December 31, 2025)
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock (5,958 shares at June 30, 2026 and 5,614 shares at December 31, 2025)
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments